165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-resistant Bacteria: Post-hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study

BACKGROUND: The efficacy and safety of cefiderocol (CFDC), a novel siderophore cephalosporin, for the treatment of serious infections due to carbapenem-resistant (CR) Gram-negative pathogens was assessed in the CREDIBLE-CR study. The current analysis evaluated clinical and microbiological outcomes b...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsunaga, Yuko, Ariyasu, Mari, Takemura, Miki, Yamano, Yoshinori, Toyoizumi, Kiichiro, Kinoshita, Masahiro, Echols, Roger, Den Nagata, Tsutae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778021/
http://dx.doi.org/10.1093/ofid/ofaa439.475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778021/
http://dx.doi.org/10.1093/ofid/ofaa439.475

Ejemplares similares